Innovative Applications of Nanoparticles in Cancer Detection and Therapy

This paper investigates the role of gold nanoparticles (GNPs) in cancer diagnosis and treatment from a biometric perspective. Gold nanoparticles are recognized as crucial tools in biomedicine due to their unique properties, including controllable size, chemical stability, and the ability to conjugate with various biomolecules. This study employs data from the Web of Science to conduct a biometric analysis of related articles, examining research trends, scientific collaborations, and practical applications of GNPs in cancer diagnosis and treatment. The findings indicate that GNPs can be used as contrast agents in medical imaging techniques such as CT and MRI, enabling early cancer detection through their ability to target cancer cells. Additionally, GNPs can serve as drug carriers to deliver anti-cancer drugs precisely to target cells, enhancing treatment efficacy while minimizing unwanted side effects. The advantages of GNPs over other nanoparticles, such as high chemical stability and lower toxicity, are also highlighted. Despite significant advancements, further research is needed to understand molecular mechanisms, evaluate long-term effects, and improve GNP production methods. The results of this study demonstrate that gold nanoparticles have a high potential for improving cancer diagnosis and treatment, thereby contributing to the betterment of patient quality of life.